Product Wiki · Recalls · Canadian Food Inspection Agency

Undeclared milk and peanuts in Erom Dr Hwang's Premium Soy Drink — recall 48956

Canadian Food Inspection Agency · Canada · 2011-09-29

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Canadian Food Inspection Agency
Recall identifier
48956
Date of alert
2011-09-29
Country / jurisdiction
Canada
Risk type
recall
Product category
Food
Product type
CFIA
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Ottawa, September 29, 2011 - The Canadian Food Inspection Agency (CFIA) and Raphaville Int'l Ltd. are warning people with allergies to milk or peanuts not to consume Erom Dr Hwang's Premium Soy Drink described below. The affected product contains milk and peanuts which are not declared on the label. All codes of Erom Dr Hwang's Premium Soy Drink, product of Korea, sold in a 102.8 fl. oz. (3040 mL ) bulk package bearing UPC 8 809111 699415 and containing 16 x 190 mL packets, are affected by this alert. This product has been distributed in Greater Toronto Area of Ontario. There have been no reported illnesses associated with the consumption of this product. Consumption of this product may cause a serious or life-threatening reaction in persons with allergies to milk or peanuts. The importer, Raphaville Int'l Ltd. , Vaughan ON is voluntarily recalling the affected product from the marketplace. The CFIA is monitoring the effectiveness of the recall.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/undeclared-milk-and-peanuts-er

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.